3 completed, 2 active not recruiting, 1 recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 2, Completed 1, Recruiting 1 |
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects Selegiline Transdermal Delivery System - Major Depressive Disorder (MDD) | Phase 1 | Active not recruiting | Corium Innovations, Inc. | 232 | 2026-08-23 | 2026-08-31 |
| A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects Estradiol/Levonorgestrel Transdermal System - Menopause, Healthy Female Participants | Phase 1 | Recruiting | Corium Innovations, Inc. | 250 | 2026-08-10 | 2026-09-10 |
| A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants Test Estradiol/Levonorgestrel Transdermal Delivery System, Climara Pro® (Estradiol/Levonorgestrel Transdermal System) - Healthy Female Participants, Postmenopause | Phase 1 | Active not recruiting | Corium Innovations, Inc. | 68 | 2026-07-01 | 2026-10-01 |
| A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects Selegiline TDS 6 mg/24 hours, EMSAM® TDS 6 mg/24 hours - Healthy Adult Participants | Phase 1 | Completed | Corium Innovations, Inc. | 92 | 2026-03-23 | 2026-07-01 |
| Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects Pharmacokinetic profiles of Selegiline TDS and EMSAM - MDD | Completed | Corium Innovations, Inc. | 12 | 2025-02-10 | 2026-02-25 | |
| Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects ZEPOSIA® indicated for the treatment of: Relapsing forms of multiple sclerosis, and active ulcerative colitis in adults - Multiple Sclerosis, Ulcerative Colitis | Completed | Corium Innovations, Inc. | 24 | 2025-02-10 | 2026-02-25 |
Colitis, Ulcerative (1) · Depressive Disorder, Major (1) · Multiple Sclerosis (1)
Estradiol (2) · Selegiline (1)
India (2) · Malaysia (2) · United States (2) · Bulgaria (1)
Damenthi Nair, MD (1) · Niraj Vasisht (1)